Recent data shows tirzepatide produces sustained weight loss in 70-85% of patients, making it a critical therapeutic tool that providers and compounding pharmacies will continue to support as long as patient demand and clinical evidence justify its use
These receptors are involved in a wide range of functions, including pigmentation, inflammation, appetite, and importantly, sexual behavior
According to the IDF Diabetes Atlas, 589 million adults aged 20 to 79 were living with diabetes worldwide in 2024, which is about 1 in 9 adults, and that number is expected to rise to 853 million by 2050
If you already have mood disorders, talk to your doctor before starting GLP-1 meds
That is not a reason to avoid the medication